e-learning
resources
Vienna 2012
Sunday, 02.09.2012
COPD and OSA: two prevalent diseases related to cardiovascular disease by common mechanism?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cardiovascular risk factors: current treatment strategies shaped for the pneumologist
D. Newby (Edinburgh, United Kingdom)
Source:
Annual Congress 2012 - COPD and OSA: two prevalent diseases related to cardiovascular disease by common mechanism?
Session:
COPD and OSA: two prevalent diseases related to cardiovascular disease by common mechanism?
Session type:
Symposium
Number:
1342
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Newby (Edinburgh, United Kingdom). Cardiovascular risk factors: current treatment strategies shaped for the pneumologist. Annual Congress 2012 - COPD and OSA: two prevalent diseases related to cardiovascular disease by common mechanism?
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Known and emerging risk factors for asthma development: is prevention possible?
Source: International Congress 2015 – Asthma: emerging risk factors and current management of the patient
Year: 2015
Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk?
Source: Eur Respir J 2015; 46: 846-849
Year: 2015
Risk factors for development of asthma
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=57
Year: 2003
Risk factors for asthma and their prevention
Source: Annual Congress 2008 - PG2 - Asthma: natural history, risk factors and overall management
Year: 2008
Scleroderma lung disease: Risk factors and treatment options
Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Year: 2010
Primary prevention of asthma: from risk and protective factors to targeted strategies for prevention
Source: Virtual Congress 2020 – Reducing the burden of asthma
Year: 2020
Treatment interruptions in patients with MDR/XDR-TB: risk factors and impact on treatment outcomes
Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline
Year: 2016
Bronchiectasis surgery: indications and risk factors?
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021
Comparing non-invasive cardiovascular risk assessment tools in COPD patients: Validation with CV events
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014
Avoiding confusion in COPD: from risk factors to phenotypes to measures of disease characterisation
Source: Eur Respir J 2011; 38: 749-751
Year: 2011
How does current knowledge on primarily hereditary risk factors for asthma and other lung diseases improve prevention, treatment and prognosis?
Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine
Year: 2012
Asthma-associated factors - Potential predictive markers for patients stratification, personalized treatments and prevention
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Risk factors for childhood asthma: Which can be avoided? A case-control study
Source: Annual Congress 2010 - Allergy and risk factors in paediatrics
Year: 2010
Treatment of risk factors
Source: ERS Course 2016
Year: 2016
Community acquired pneumonia: an increased risk for subsequent cardiovascular events?
Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Year: 2020
Compliance to asthma treatment and its risk factors
Source: Eur Respir J 2005; 26: Suppl. 49, 508s
Year: 2005
Risk factors for paediatric asthma
Source: Annual Congress 2013 –Paediatric Year in Review
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept